6-51748201-C-A

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_138694.4(PKHD1):​c.9415G>T​(p.Asp3139Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00566 in 1,614,030 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0039 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0058 ( 20 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:14

Conservation

PhyloP100: 0.745
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008653432).
BP6
Variant 6-51748201-C-A is Benign according to our data. Variant chr6-51748201-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 167479.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=8, Uncertain_significance=1, Benign=3}. Variant chr6-51748201-C-A is described in Lovd as [Likely_benign]. Variant chr6-51748201-C-A is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAdExome4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PKHD1NM_138694.4 linkuse as main transcriptc.9415G>T p.Asp3139Tyr missense_variant 58/67 ENST00000371117.8 NP_619639.3 P08F94-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkuse as main transcriptc.9415G>T p.Asp3139Tyr missense_variant 58/671 NM_138694.4 ENSP00000360158.3 P08F94-1
PKHD1ENST00000340994.4 linkuse as main transcriptc.9415G>T p.Asp3139Tyr missense_variant 58/615 ENSP00000341097.4 P08F94-2

Frequencies

GnomAD3 genomes
AF:
0.00395
AC:
601
AN:
152134
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.00810
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00629
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00415
AC:
1041
AN:
250812
Hom.:
3
AF XY:
0.00447
AC XY:
606
AN XY:
135520
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.000868
Gnomad ASJ exome
AF:
0.000895
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00301
Gnomad FIN exome
AF:
0.00753
Gnomad NFE exome
AF:
0.00621
Gnomad OTH exome
AF:
0.00409
GnomAD4 exome
AF:
0.00583
AC:
8528
AN:
1461778
Hom.:
20
Cov.:
34
AF XY:
0.00575
AC XY:
4180
AN XY:
727204
show subpopulations
Gnomad4 AFR exome
AF:
0.00108
Gnomad4 AMR exome
AF:
0.000850
Gnomad4 ASJ exome
AF:
0.000651
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00326
Gnomad4 FIN exome
AF:
0.00629
Gnomad4 NFE exome
AF:
0.00675
Gnomad4 OTH exome
AF:
0.00495
GnomAD4 genome
AF:
0.00395
AC:
601
AN:
152252
Hom.:
1
Cov.:
32
AF XY:
0.00392
AC XY:
292
AN XY:
74424
show subpopulations
Gnomad4 AFR
AF:
0.00144
Gnomad4 AMR
AF:
0.000720
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00249
Gnomad4 FIN
AF:
0.00810
Gnomad4 NFE
AF:
0.00629
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00532
Hom.:
1
Bravo
AF:
0.00301
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00477
AC:
41
ExAC
AF:
0.00418
AC:
508
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00436
EpiControl
AF:
0.00569

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:14
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal recessive polycystic kidney disease Uncertain:1Benign:6
Likely benign, criteria provided, single submitterclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical CenterAug 18, 2015- -
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtFeb 01, 2017- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterliterature onlyCounsylApr 09, 2014- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Likely benign, criteria provided, single submitterclinical testingMolecular Genetics, Royal Melbourne HospitalSep 04, 2023- -
Benign, no assertion criteria providedclinical testingNatera, Inc.May 23, 2017- -
not specified Benign:3
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 16, 2015- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 14, 2019Variant summary: PKHD1 c.9415G>T (p.Asp3139Tyr) results in a non-conservative amino acid change located in the right handed beta helix domain of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0041 in 277424 control chromosomes, predominantly at a frequency of 0.0075 within the Finnish subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within Finnish control individuals in the gnomAD database is approximately 1.061 fold of the estimated maximal expected allele frequency for a pathogenic variant in PKHD1 causing Polycystic Kidney and Hepatic Disease phenotype (0.0071), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Finnish origin. c.9415G>T has been reported in the literature in individuals affected with Polycystic Kidney and Hepatic Disease (Bergmann_2005, Furu_2003, Gunay-Aygun_2010, Losekoot_2005, Onuchi_2002, rossetti_2003, Ward_2002), however, authors predominantly refer to the variant as a polymorphism. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant as likely benign/benign. Based on the evidence outlined above, the variant was classified as benign. -
not provided Benign:3
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024PKHD1: BP4, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 12, 2020This variant is associated with the following publications: (PMID: 12874454, 26990548, 11898128, 21228398) -
Polycystic kidney disease Benign:1
Benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The PKHD1 p.Asp3139Tyr variant was identified in 6 of 888 proband chromosomes (frequency: 0.007) from individuals or families with ARPKD and was present in 13 of 1440 control chromosomes (frequency: 0.009) from healthy individuals (Bergmann 2004, Bergmann 2005, Gunay-Aygun 2010, Losekoot 2005, Rosetti 2003, Sharp 2005). The variant was also identified in dbSNP (ID: rs45503297) as "With other allele", ClinVar (classified as benign by Invitae; and as likely benign by Prevention Genetics, Counsyl, and three other submitters), LOVD 3.0 (4x as likely benign), and in RWTH AAachen University ARPKD database (as polymorphism). The variant was identified in control databases in 1133 of 276504 chromosomes (4 homozygous) at a frequency of 0.004, increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 27 of 24022 chromosomes (freq: 0.001), Other in 19 of 6456 chromosomes (freq: 0.003), Latino in 34 of 34376 chromosomes (freq: 0.0009), European in 757 of 126108 chromosomes (freq: 0.006), Ashkenazi Jewish in 9 of 10126 chromosomes (freq: 0.001), Finnish in 193 of 25786 chromosomes (freq: 0.007), and South Asian in 94 of 30780 chromosomes (freq: 0.003), while the variant was not observed in the East Asian population. The p.Asp3139 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information, this variant meets our laboratory criteria to be classified as benign. -
Polycystic kidney disease 4 Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabMay 18, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
14
DANN
Benign
0.90
DEOGEN2
Benign
0.29
T;.
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.32
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.46
T;T
M_CAP
Benign
0.034
D
MetaRNN
Benign
0.0087
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.7
L;L
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.9
N;N
REVEL
Benign
0.17
Sift
Benign
1.0
T;T
Sift4G
Benign
0.20
T;T
Polyphen
0.0070
B;B
Vest4
0.26
MVP
0.92
MPC
0.078
ClinPred
0.0062
T
GERP RS
2.9
Varity_R
0.034
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs45503297; hg19: chr6-51612999; COSMIC: COSV105240949; API